PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO) today announced that Michael D. Becker, president and chief executive officer, and Kevin J. Bratton, senior vice president and chief financial officer, will present an overview of the Company at two investor conferences in September.
